21 results
8-K
EX-99.1
IOBT
IO Biotech Inc
14 May 24
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
8:30am
with the strength of expertise we have added to our leadership team with the additions of Marjan Shamsaei as Senior Vice President, Commercial and Portfolio Lead
8-K
EX-99.2
IOBT
IO Biotech Inc
11 Aug 23
IO Biotech Announces 2023 Second Quarter Results
8:31am
2015 to September 2020. She has also held leadership positions at Boehringer Ingelheim as Senior Vice President and General Manager in its Biosimilars … Business, and at IQVIA as Vice President of Global Business Partnerships Commercial Solutions.
Ms. Hunter also held senior leadership positions
8-K
EX-99.1
zjrlt
11 Aug 23
IO Biotech Announces 2023 Second Quarter Results
8:31am
8-K
EX-99.2
k2j7gdw
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
PRE 14A
xk80n2be 6v
14 Apr 23
Preliminary proxy
4:39pm
8-K
EX-99.1
4skpf7omvf
13 Oct 22
IO Biotech Announces Appointment of New Chief Financial Officer
4:05pm
DEF 14A
898tavhiig82
14 Apr 22
Definitive proxy
4:02pm
10-K
rgnlc5tx64o8
31 Mar 22
Annual report
5:07pm
8-K
EX-99.1
9jmrdwww5 0tu002det
31 Mar 22
IO Biotech Announces Year-End Results for 2021
4:27pm
8-K
EX-99.1
eyyqy80f9dhrgha
3 Mar 22
IO Biotech Announces Appointment of David V. Smith to its Board of Directors
4:28pm
10-Q
2vg bir3k1bldcvxj
17 Dec 21
Quarterly report
4:55pm
424B4
7pi947dwfr kibsp0w
8 Nov 21
Prospectus supplement with pricing info
5:20pm
S-1
ubshtcti 9fv8ar4bxs2
15 Oct 21
IPO registration
5:18pm
DRS/A
vi5pb9ukl0tm0yql8
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
xpfh0 wbr
9 Aug 21
Draft registration statement (amended)
12:00am